KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025)

Edwards Lifesciences has reported Gains from Investment Securities over the past 17 years, most recently at $7.4 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $7.4 million for Q4 2025, down 87.18% from a year ago — trailing twelve months through Dec 2025 was -$13.4 million (down 123.43% YoY), and the annual figure for FY2025 was $7.4 million, down 86.55%.
  • Gains from Investment Securities for Q4 2025 was $7.4 million at Edwards Lifesciences, up from -$12.5 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for EW hit a ceiling of $96.6 million in Q4 2021 and a floor of -$102.6 million in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was -$500000.0 (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 2510.81% in 2021 and later plummeted 1236.36% in 2022.
  • Edwards Lifesciences' Gains from Investment Securities stood at $96.6 million in 2021, then tumbled by 70.5% to $28.5 million in 2022, then crashed by 37.89% to $17.7 million in 2023, then surged by 225.99% to $57.7 million in 2024, then plummeted by 87.18% to $7.4 million in 2025.
  • The last three reported values for Gains from Investment Securities were $7.4 million (Q4 2025), -$12.5 million (Q3 2025), and -$8.2 million (Q2 2025) per Business Quant data.